Instituto Portugues de Oncologia Do Porto Francisco Gentil Epe - PPDS
Lisbon 1099-023
0 studies enrolling now ยท 1 studies all time
What they study most
Melanoma
Studies at this site
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma
โ Completed